Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series

NCT00392951 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.

NCT NCT00392951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00392951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sirolimus for Patients With Chronic and/or Refractory Autoimmune Cytopenias: A Pilot Series
Lead sponsor
Children's Hospital of Philadelphia
Phase
Phase 1/2
Overall status
Completed
Start date
December 31, 2006
Completion date
February 29, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, hemolytic, autoimmune, autoimmune lymphoproliferative syndrome (alps), autoimmune neutropenia, autoimmune pancytopenia, evans syndrome, idiopathic thrombocytopenic purpura, inflammatory bowel disease, lupus erythematosus, systemic, rheumatoid arthritis